GlassScriptPhysician profile
George D Lyle
NPI 1831122811
$519.44
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2020: $217 · 2021: $176.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $103.69 | 2019-2020 | |
| Stryker Corporation | $102.23 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $80.52 | 2020-2021 | |
| Ethicon US, LLC | $47.75 | 2020 | |
| Alk-Abello, INC | $44.27 | 2020-2021 | |
| Minaris Medical America, INC. | $44.00 | 2021 | |
| Genzyme Corporation | $32.70 | 2020-2021 | |
| Olympus America INC. | $30.25 | 2019 | |
| Siemens Medical Solutions USA, INC. | $20.52 | 2020 | |
| Checkpoint Surgical, INC | $13.51 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Lyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.